Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2021 Jan 7;27(3):262.e1–262.e11. doi: 10.1016/j.jtct.2021.01.004

Table 6.

Causes of rash in patients receiving chlorhexidine gluconate

High (>75%)
N=25
Medium (50-75%)
N=33
Low (<50%)
N=45
Total No. Rash 14 (56%) 13 (39.4%) 16 (35.6%)
Medication-Related 4 3 2
Engraftment Syndrome 1 3 1
Folliculitis 2 2 3
Dermatitis 0 1 1
GVHD1 0 1 1
Infection 0 1 1
Other 4 0 0
Unexplained 3 2 7

GVHD: Graft-versus-Host Disease